1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them

A compound selected from those of formula (I):

• wherein:
• R1 represents hydrogen, C3-C7cycloalkyl, benzyl or linear or branched C1-C6alkyl, wherein the alkyl group may be saturated or unsaturated and may be optionally substituted by a hydroxy or C3-C7cycloalkyl group or by one or more halogen atoms,
• R2, R3, R4 and R5, which may be the same or different, each represent hydrogen;
• hydroxy;
• methyl;
• —OSO2R10;
• —OCOR10;
• or linear or branched, saturated or unsaturated C1-C6alkoxy which may be optionally substituted by a methoxy or —(CO)—NR12R′12 group, or R2 and R3, or R3 and R4, or R4 and R5 together form —O—(CH2)q—O—, —O—CH═CH—O—or —O—CH═CH—,
• R6, R7, R8 and R9, which may be the same or different, each represent hydrogen or linear or branched, saturated or unsaturated C1-C6alkoxy, or R6 and R7, or R7 and R8, or R8 and R9 together form —O—(CH2)q—O—,
• R10 represents linear or branched C1-C6alkoxy, NR11R′11 or linear or branched C1-C6alkyl which is optionally substituted by one or more halogen atoms,
• R11 and R′11, which may be the same or different, each represent hydrogen or linear or branched C1-C6alkyl, or R11 and R′11 together with the nitrogen atom carrying them form a monocyclic or bicyclic, 5- to 8-membered, nitrogen-containing heterocycle optionally containing another hetero atom selected from O and N, said heterocycle being optionally substituted by one or more halogen atoms,
• R12 and R′12, which may be the same or different, each represent hydrogen or linear or branched C1-C6alkyl,
• X represents O, NH or CH2,
• m and p, which may be the same or different, each represent 0 or 1,
• n and q, which may be the same or different, each represent 1 or 2,
• its optical isomers and addition salts thereof with a pharmaceutically acceptable acid.